Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 22

Trial Status

Completed2
Other2

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT03217747Phase 1/2Active Not Recruiting
Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies
Advanced Malignant Solid NeoplasmCastration-Resistant Prostate CarcinomaMalignant Solid Neoplasm+7 more
PrincipalinvestigatorStart date: 2017-08-02
NCT02721732Phase 2Active Not Recruiting
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
PrincipalinvestigatorStart date: 2016-08-15
NCT02159989Phase 1Completed
Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
PrincipalinvestigatorStart date: 2014-06-18

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Castration-Resistant Prostate CarcinomaMetastatic Malignant Solid NeoplasmMetastatic Prostate Carcinoma+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmCancerMetastatic Malignant Solid Neoplasm+2 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score5%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmCancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Lorenzo Cohen, PhD

M.D. Anderson Cancer Center

Related
17 trials

Shared therapeutic areas:

CancerOvarian Carcinoma

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score2%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Cancer
Similarity Score1%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Cancer
Similarity Score1%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer
Similarity Score1%

Emily Y Chew, M.D.

National Eye Institute (NEI)

Related
17 trials

Shared therapeutic areas:

Cancer
Similarity Score1%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Cancer
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT03217747Phase 1/2PrincipalInvestigator

Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

Advanced Malignant Solid NeoplasmCastration-Resistant Prostate CarcinomaMalignant Solid Neoplasm+7 more
Active Not Recruiting
NCT02721732Phase 2PrincipalInvestigator

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
Active Not Recruiting
NCT02159989Phase 1PrincipalInvestigator

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
Completed
NCT00678769Phase 1PrincipalInvestigator

Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic Cancer

Malignant Neoplasm
Completed

All 4 trials loaded